Taylor Goodspeed focuses on regulatory, compliance, and civil litigation matters involving the health care industry. She counsels and defends hospitals, health systems, life sciences companies, and other health care entities in civil fraud and abuse investigations and litigation, particularly under the civil False Claims Act (FCA) and similar state laws. She also helps steer clients through high-profile investigations from federal and state agencies. She routinely provides strategic counsel and guidance to digital health and medical technology companies in navigating the current health care regulatory scheme.
Taylor worked closely with the in-house legal team at a global biopharmaceutical company while on secondment in its litigation and government investigations group. During that time, she managed a wide variety of matters including civil litigation, interactions with enforcement authorities, and internal investigations across the globe.
Taylor has also counseled health systems and emerging companies on federal and state anti-kickback statutes, federal and state referral prohibitions, licensure requirements, and state corporate practice of medicine provisions. Prior to joining Jones Day, Taylor coauthored multiple publications on public attitudes towards noninvasive prenatal testing, such as cell-free fetal DNA technology.
Taylor maintains an active pro bono practice, serving on Jones Day's Anti-Human Trafficking Committee and on the American Hospital Association's (AHA) Human Trafficking Advisory Committee. She has also presented widely on the Firm's pro bono anti-trafficking efforts.
Taylor is currently serving her second term as a member of the Women's Leadership Council for the American Health Law Association (AHLA).
- University of Pennsylvania (J.D. 2017; Articles Editor, University of Pennsylvania Law Review; Master of Bioethics 2017, Perelman School of Medicine); Stanford University (B.A. in Human Biology 2012; B.A. in Classics 2012)
- New York and California